A novel synthesised STAT3 inhibitor exerts potent anti‐tumour activity by inducing lysosome‐dependent cell death
2025 · British Journal of Pharmacology · 3 citations
https://doi.org/10.1111/bph.70071
Luoyang Central Hospital Affiliated to Zhengzhou University(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
7
Papers
153
Citations
4
h-index
3
i10-index
Marvin Xuejun Xu is an academic researcher from Luoyang Central Hospital Affiliated to Zhengzhou University. The author has contributed to research in topics: Cytokine Signaling Pathways and Interactions & Synthesis and biological activity & Cancer Mechanisms and Therapy. The author has an h-index of 4, co-authored 6 publications.
ORCID: 0000-0003-0413-7920Click to start Chat